UPDATE 2-AstraZeneca's immunotherapy drug wins key lung cancer approval
February 19, 2018 at 03:13 AM EST
* Rival BMS, Merck, Roche drugs approved for later disease (Adds shares, analyst reaction)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|